SlideShare a Scribd company logo
1 of 44
Induced resistance to  S. aureus  in marine environmental biofilms John Lafleur 3/23/09
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
 
a)  S. aureus epidemiology & MDR
Crum et al., 2003. The American Journal of Medicine 119:943-51
Crum et al., 2003. The American Journal of Medicine 119:943-51
Turnidge and Bell. 2000. Microbial Drug Resistance. 6(3):223-8
b)  Common medical biofilms
Costerton et al.,1999. Science. 284:1318-22
Camargo et al., 2005. International Journal of Gynecology and Obstetrics . 90:148—9
von Eiff et al., Drugs 2005; 65 (2): 179-214
von Eiff et al., Drugs 2005; 65 (2): 179-214 ,[object Object],[object Object],[object Object],[object Object]
c)  The problem with antibiotics
Bacteria in biofilms up to 1000X more resistant to antibotics   Costerton et al., 1985. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 27(4):619-24
D'Costa, et al., 2006. Science. 311:374-7
 
[object Object]
d)  Induced antibiosis in bacteria
Mearns-Spragg et al. 1998. Letters in Applied Microbiology  27:142–146
[object Object]
Is there evidence that a complex, multi-species environmental biofilm might amplify any antibacterial activity among individual members of its bacterial consortia?
Burmolle et al., 2006. APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 76(6):3916– 23
e) Putting it together ,[object Object],[object Object],[object Object]
[object Object]
[object Object]
II. Materials and Methods
III. Results
S. aureus  agar with biofilm treated with UV
S. aureus  agar with biofilm no UV
Percentage of area per high-powered field covered by  S. aureus  micro-colonies.
Comparison of percentages of area of  S. aureus  biofilm growth with associated P values . <0.001 S. aureus  agar with biofilm no UV (0.07%) vs.  S. aureus  agar with biofilm, pos. UV (1.56%) 0.14** S. aureus  agar with biofilm pos. UV (1.56%) vs. Plain agar with biofilm, pos. UV (1.30%) <0.001  S. aureus  agar with biofilm no UV (0.07%) vs. Plain agar with biofilm, no UV (0.13%) <0.001 Baseline (0.05%) vs.  S. aureus  agar with biofilm, no UV (0.07%) P value
Percentage of  S. aureus  microcolonies with less than 4 cells at baseline and after incubation by treatment type .
Percentage of  S. aureus  microcolonies with less than 4 cells at baseline and after incubation  by treatment types  (Sd =standard deviation). nd nd Plain agar no biofilm nd nd S. aureus  agar no biofilm +/-29% 53% Plainagar with biofilm, UV exposed +/-14% 5% S. aureus  agar with biofilm, UV exposed +/-37% 68% Plain agar with biofilm +/-24% 91% S. aureus  spent medium agar with biofilm +/-31% 78% Baseline Sd Percent <4 cells per microcolony
Table 2.   Comparison of percentages of microcolonies with fewer than 4 cells  per micrcolony with associated p values <0.001 S. aureus  agar with biofilm no UV (91%) vs.  S. aureus  agar with biofilm, pos. UV (5%) <0.001 S. aureus  agar with biofilm no UV (91%) vs. Plain agar with biofilm, no UV (68%) 0.10 ** Baseline (78%) vs.  Plain agar with biofilm, no UV (68%) 0.02 Baseline (78%) vs.  S. aureus  agar with biofilm, no UV (91%) P value
IV Australia
Two day incubation--Dapi stain
Two day incubation--live/dead stain
Two day incubation—live/dead stain
P values for comparison S. aureus area coverage  S. aureus agar versus plain agar:   ,[object Object],[object Object],[object Object]
Next steps
[object Object],[object Object]
 
[object Object],[object Object],[object Object],[object Object]
Questions?

More Related Content

What's hot

OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...
OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...
OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...EuFMD
 
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...EuFMD
 
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...EuFMD
 
EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...
EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...
EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...EWMAConference
 
OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...
OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...
OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...EuFMD
 
characterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescharacterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescamilomesa22
 
identification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenesidentification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenescamilomesa22
 
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...EuFMD
 
Looking Back at Mycobacterium tuberculosis Mouse Efficacy Testing To Move Ne...
Looking Back at Mycobacterium tuberculosis Mouse  Efficacy Testing To Move Ne...Looking Back at Mycobacterium tuberculosis Mouse  Efficacy Testing To Move Ne...
Looking Back at Mycobacterium tuberculosis Mouse Efficacy Testing To Move Ne...Sean Ekins
 
50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...
50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...
50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...IOSR Journals
 
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...EuFMD
 
EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...
EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...
EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...EWMAConference
 
03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibila
03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibila03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibila
03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibilabrnmomentum
 
OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...
OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...
OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...EuFMD
 
OS20 - Duration of immunity in cattle and pigs under national vaccination pro...
OS20 - Duration of immunity in cattle and pigs under national vaccination pro...OS20 - Duration of immunity in cattle and pigs under national vaccination pro...
OS20 - Duration of immunity in cattle and pigs under national vaccination pro...EuFMD
 
Affects of Urban Environments on Mycobacteriophage Activity- hcmgkmjm
Affects of Urban Environments on Mycobacteriophage Activity- hcmgkmjmAffects of Urban Environments on Mycobacteriophage Activity- hcmgkmjm
Affects of Urban Environments on Mycobacteriophage Activity- hcmgkmjmKatherine Milliken
 

What's hot (18)

OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...
OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...
OS20 - Comparison of diagnostic performances of three commercial ELISA kits f...
 
QMB Poster
QMB PosterQMB Poster
QMB Poster
 
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
OS20 - Development of Solid-phase Competition ELISA for detection of type-A F...
 
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
OS20 - Enhanced diagnosis efficacy of a newly developed kit for FMDV in POOL ...
 
EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...
EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...
EWMA 2013 - Ep451 An in vitro and clinical assessment of a nonadherent, antim...
 
OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...
OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...
OS20 - Exploring foot-and-mouth disease virus antibody affinity using bio-lay...
 
characterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenescharacterization of FQ Non-susceptible S. Pyogenes
characterization of FQ Non-susceptible S. Pyogenes
 
identification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenesidentification and characterization of FQ-non-susceptable S. Pyogenes
identification and characterization of FQ-non-susceptable S. Pyogenes
 
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
OS20 - Validation of recombinant protein-based ELISA for detection of antibod...
 
Looking Back at Mycobacterium tuberculosis Mouse Efficacy Testing To Move Ne...
Looking Back at Mycobacterium tuberculosis Mouse  Efficacy Testing To Move Ne...Looking Back at Mycobacterium tuberculosis Mouse  Efficacy Testing To Move Ne...
Looking Back at Mycobacterium tuberculosis Mouse Efficacy Testing To Move Ne...
 
50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...
50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...
50 Hz Frequency Magnetic Field Effects On Pseudomonas Aeruginosa And Bacillus...
 
G4 ppt
G4 ppt G4 ppt
G4 ppt
 
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
OS20 - FMD serological blocking ELISA based on VHH for post-vaccination monit...
 
EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...
EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...
EWMA 2013-Ep450-COMPARISON OF ANTIMICROBIAL EFFICACY OF SILVER-CONTAINING AND...
 
03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibila
03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibila03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibila
03 BRN Research Forum Bronquiectasias. Parte III por Oriol Sibila
 
OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...
OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...
OS20 - Genetic characterization of serotype and genetic relatedness of foot-a...
 
OS20 - Duration of immunity in cattle and pigs under national vaccination pro...
OS20 - Duration of immunity in cattle and pigs under national vaccination pro...OS20 - Duration of immunity in cattle and pigs under national vaccination pro...
OS20 - Duration of immunity in cattle and pigs under national vaccination pro...
 
Affects of Urban Environments on Mycobacteriophage Activity- hcmgkmjm
Affects of Urban Environments on Mycobacteriophage Activity- hcmgkmjmAffects of Urban Environments on Mycobacteriophage Activity- hcmgkmjm
Affects of Urban Environments on Mycobacteriophage Activity- hcmgkmjm
 

Similar to Induced Resistance To S

Antibiotic Resistance form food of animal origint- Debatable issue
Antibiotic Resistance form food of animal origint- Debatable issueAntibiotic Resistance form food of animal origint- Debatable issue
Antibiotic Resistance form food of animal origint- Debatable issueAsima Zehra
 
Microbiological culture sensitivity test
Microbiological culture sensitivity testMicrobiological culture sensitivity test
Microbiological culture sensitivity testAkhil Joseph
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Scientific Review
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...Scientific Review SR
 
s13568-014-0042-y
s13568-014-0042-ys13568-014-0042-y
s13568-014-0042-yIan Durie
 
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdfSyngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdfSyngulon
 
surender credit seminar.ppt silver nanoparticles
surender credit seminar.ppt silver nanoparticlessurender credit seminar.ppt silver nanoparticles
surender credit seminar.ppt silver nanoparticlesSurenderKumar488475
 
Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...
Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...
Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...IJERA Editor
 
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...iosrjce
 
CAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptx
CAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptxCAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptx
CAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptxLarry B. Abang
 
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...kamal shrestha
 
Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Cassandra Quave
 
Testing the efficacy of fungicides on spore germination of Alternaria solani
Testing the efficacy of fungicides on spore germination of Alternaria solaniTesting the efficacy of fungicides on spore germination of Alternaria solani
Testing the efficacy of fungicides on spore germination of Alternaria solaniUPL
 
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...AdeyemiKayode2
 
Chaithra,m ph d 1st seminar
Chaithra,m  ph d 1st seminarChaithra,m  ph d 1st seminar
Chaithra,m ph d 1st seminarchaithram11
 
Syngulon - Selection technology July 2022.pdf
Syngulon - Selection technology July 2022.pdfSyngulon - Selection technology July 2022.pdf
Syngulon - Selection technology July 2022.pdfSyngulon
 
Prevalence and antibiotic susceptibility patterns of methicillin resistant st...
Prevalence and antibiotic susceptibility patterns of methicillin resistant st...Prevalence and antibiotic susceptibility patterns of methicillin resistant st...
Prevalence and antibiotic susceptibility patterns of methicillin resistant st...Alexander Decker
 

Similar to Induced Resistance To S (20)

Antibiotic Resistance form food of animal origint- Debatable issue
Antibiotic Resistance form food of animal origint- Debatable issueAntibiotic Resistance form food of animal origint- Debatable issue
Antibiotic Resistance form food of animal origint- Debatable issue
 
Microbiological culture sensitivity test
Microbiological culture sensitivity testMicrobiological culture sensitivity test
Microbiological culture sensitivity test
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri M...
 
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...Multidrug Resistance Pattern of Staphylococcus Aureus Isolates  in Maiduguri ...
Multidrug Resistance Pattern of Staphylococcus Aureus Isolates in Maiduguri ...
 
s13568-014-0042-y
s13568-014-0042-ys13568-014-0042-y
s13568-014-0042-y
 
Pseudomonas Aeruginosa
Pseudomonas AeruginosaPseudomonas Aeruginosa
Pseudomonas Aeruginosa
 
Bio burden
Bio burdenBio burden
Bio burden
 
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdfSyngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdf
 
surender credit seminar.ppt silver nanoparticles
surender credit seminar.ppt silver nanoparticlessurender credit seminar.ppt silver nanoparticles
surender credit seminar.ppt silver nanoparticles
 
Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...
Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...
Anti-Adhesion and Anti-Biofilm Effectiveness of Disinfectants Used In Hemodia...
 
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...
Comparative Study of the Prevalence and Antibiogram of Bacterial Isolates fro...
 
CAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptx
CAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptxCAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptx
CAUSES OF ANTIBIOTIC RESISTANCE IN SUSCEPTIBILTY TESTING.pptx
 
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
 
Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015
 
Testing the efficacy of fungicides on spore germination of Alternaria solani
Testing the efficacy of fungicides on spore germination of Alternaria solaniTesting the efficacy of fungicides on spore germination of Alternaria solani
Testing the efficacy of fungicides on spore germination of Alternaria solani
 
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
Isolation, Characterization, and Antibiotics Resistance Profile of Staphyloco...
 
Chaithra,m ph d 1st seminar
Chaithra,m  ph d 1st seminarChaithra,m  ph d 1st seminar
Chaithra,m ph d 1st seminar
 
Syngulon - Selection technology July 2022.pdf
Syngulon - Selection technology July 2022.pdfSyngulon - Selection technology July 2022.pdf
Syngulon - Selection technology July 2022.pdf
 
Sdrajani
SdrajaniSdrajani
Sdrajani
 
Prevalence and antibiotic susceptibility patterns of methicillin resistant st...
Prevalence and antibiotic susceptibility patterns of methicillin resistant st...Prevalence and antibiotic susceptibility patterns of methicillin resistant st...
Prevalence and antibiotic susceptibility patterns of methicillin resistant st...
 

Induced Resistance To S

  • 1. Induced resistance to S. aureus in marine environmental biofilms John Lafleur 3/23/09
  • 2.
  • 3.  
  • 4. a) S. aureus epidemiology & MDR
  • 5. Crum et al., 2003. The American Journal of Medicine 119:943-51
  • 6. Crum et al., 2003. The American Journal of Medicine 119:943-51
  • 7. Turnidge and Bell. 2000. Microbial Drug Resistance. 6(3):223-8
  • 8. b) Common medical biofilms
  • 9. Costerton et al.,1999. Science. 284:1318-22
  • 10. Camargo et al., 2005. International Journal of Gynecology and Obstetrics . 90:148—9
  • 11. von Eiff et al., Drugs 2005; 65 (2): 179-214
  • 12.
  • 13. c) The problem with antibiotics
  • 14. Bacteria in biofilms up to 1000X more resistant to antibotics Costerton et al., 1985. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 27(4):619-24
  • 15. D'Costa, et al., 2006. Science. 311:374-7
  • 16.  
  • 17.
  • 18. d) Induced antibiosis in bacteria
  • 19. Mearns-Spragg et al. 1998. Letters in Applied Microbiology 27:142–146
  • 20.
  • 21. Is there evidence that a complex, multi-species environmental biofilm might amplify any antibacterial activity among individual members of its bacterial consortia?
  • 22. Burmolle et al., 2006. APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 76(6):3916– 23
  • 23.
  • 24.
  • 25.
  • 26. II. Materials and Methods
  • 28. S. aureus agar with biofilm treated with UV
  • 29. S. aureus agar with biofilm no UV
  • 30. Percentage of area per high-powered field covered by S. aureus micro-colonies.
  • 31. Comparison of percentages of area of S. aureus biofilm growth with associated P values . <0.001 S. aureus agar with biofilm no UV (0.07%) vs. S. aureus agar with biofilm, pos. UV (1.56%) 0.14** S. aureus agar with biofilm pos. UV (1.56%) vs. Plain agar with biofilm, pos. UV (1.30%) <0.001 S. aureus agar with biofilm no UV (0.07%) vs. Plain agar with biofilm, no UV (0.13%) <0.001 Baseline (0.05%) vs. S. aureus agar with biofilm, no UV (0.07%) P value
  • 32. Percentage of S. aureus microcolonies with less than 4 cells at baseline and after incubation by treatment type .
  • 33. Percentage of S. aureus microcolonies with less than 4 cells at baseline and after incubation by treatment types (Sd =standard deviation). nd nd Plain agar no biofilm nd nd S. aureus agar no biofilm +/-29% 53% Plainagar with biofilm, UV exposed +/-14% 5% S. aureus agar with biofilm, UV exposed +/-37% 68% Plain agar with biofilm +/-24% 91% S. aureus spent medium agar with biofilm +/-31% 78% Baseline Sd Percent <4 cells per microcolony
  • 34. Table 2. Comparison of percentages of microcolonies with fewer than 4 cells per micrcolony with associated p values <0.001 S. aureus agar with biofilm no UV (91%) vs. S. aureus agar with biofilm, pos. UV (5%) <0.001 S. aureus agar with biofilm no UV (91%) vs. Plain agar with biofilm, no UV (68%) 0.10 ** Baseline (78%) vs. Plain agar with biofilm, no UV (68%) 0.02 Baseline (78%) vs. S. aureus agar with biofilm, no UV (91%) P value
  • 39.
  • 41.
  • 42.  
  • 43.